Key result
A 57-year-old male with COVID-19 developed new-onset symptomatic ventricular bigeminy and trigeminy, highlighting a rare potential association.
Why the study?
Electrocardiogram analyses of COVID-19 patients are limited, and ventricular bigeminy associated with COVID-19 is exceedingly rare, requiring further study to determine its incidence and clinical significance.
Case Report (n=1)
No
This case highlights a rare potential association between COVID-19 and ventricular bigeminy/trigeminy.
Answers are grounded in this paper and cite their sources.
Ventricular bigeminy in COVID-19 should not yet change practice; leaves open its incidence and clinical significance for prospective study.
Cardiac manifestations of COVID-19 are well-described in the current literature, although electrocardiogram analyses of COVID-19 patients are limited. The most common arrhythmias experienced by patients with COVID-19 include sinus tachycardia and atrial fibrillation. Ventricular bigeminy associated with COVID-19 is exceedingly rare and requires further studies to determine its incidence and clinical significance. Here, we present the case of a 57-year-old male with no prior cardiac history who was found to have COVID-19 and new-onset, symptomatic premature ventricular contraction bigeminy. This case highlights a rare potential association between COVID-19 and ventricular bigeminy/trigeminy.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2023) conducted a case report in COVID-19 with ventricular bigeminy and trigeminy (n=1). COVID-19 was evaluated on Electrocardiogram findings. A 57-year-old male with COVID-19 developed new-onset symptomatic ventricular bigeminy and trigeminy, highlighting a rare potential association.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: